AI Clarity Score Assesses Five-Year Breast Cancer Risk from Mammogram Views
At a recent event, radiology expert Connie Lehman discussed an AI model that analyzes mammogram images to predict breast cancer likelihood. The tool aims to improve targeted screening beyond traditional methods. Lehman highlighted ongoing challenges in women's health research and data diversity.
Substrate placeholder — needs reviewAn AI model analyzes four standard mammogram views to estimate a woman's likelihood of developing breast cancer over the next five years, Connie Lehman of Clarity, Inc. stated in an interview. The model takes inputs of two views from the right breast and two from the left breast, extracted from routine screening mammograms, and outputs a percentage score, Lehman explained.
She described this as a more targeted approach compared to traditional mammograms, which she said have limitations and are insufficient for personalized care. Lehman expressed interest in women's health and global health access, noting that she became excited about radiology due to the power of imaging the body.
"The power of the image, I thought it was so incredible and so untapped in healthcare, just the power of imaging the body, and the technology by which we can take images outside and inside the body," Lehman said.
The interview took place at the Imagination in Action event on April 9 and 10, where Boston Globe reporter Aaron Pressman spoke with Lehman. Artificial intelligence is used in radiology to help clinicians read scans, providing a foundation for such advancements. Lehman referenced early research on this type of technology in the 1970s.
She highlighted cases like an MIT professor who was diagnosed with breast cancer and was shocked by how little science was used to determine her next steps after diagnosis. A broadcast professional also battled breast cancer, despite an absence of family medical history, Lehman noted.
"She was shocked by how little science was being used to determine exactly what she should do next," Lehman said of the professor's experience.
Lehman pointed to broader challenges in health research, including NIH studies that exclude female mice because their cycles mess up the data. "The mammogram isn't enough," Lehman stated, emphasizing the need for tools beyond a one-size-fits-all screening paradigm.
Transparency
Rewrite shows mild promotional valence toward AI tool via source quotes, but lacks severe slants; lede centers on tool description without misdirection.
Valence skew: positive adjectives for AI contrast negatively with traditional methods
AI tools in radiology may introduce biases from historical data gaps, potentially exacerbating disparities in women's cancer detection despite efficiency gains.
Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.
Sources framed at 12; our rewrite scored 28 — in line with the sources.
Story details
Related Stories
thenextweb.comInstagram patches vulnerability allowing account hijacks through Meta AI chatbot
Instagram restored access after hackers used its AI support chatbot to add new emails and reset passwords on multiple accounts. The company confirmed the issue was resolved Monday.
japantoday.comAnthropic Confidentially Files for IPO After Raising $65 Billion
The artificial intelligence company behind the Claude chatbot submitted its filing on Monday, weeks after completing a funding round that more than doubled its valuation from February. Anthropic did not disclose the size or terms of the offering. The move comes as the global IPO…
New York PostFlorida Attorney General Sues OpenAI and Sam Altman, Alleging ChatGPT Caused Harm to Users
Florida Attorney General James Uthmeier filed an 83-page civil complaint Monday in the state's 10th Judicial Circuit against OpenAI and its chief executive Sam Altman.